Mathilde Kouwenhoven
Overview
Explore the profile of Mathilde Kouwenhoven including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
184
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kucukosmanoglu A, Scoarta S, Houweling M, Spinu N, Wijnands T, Geerdink N, et al.
Clin Cancer Res
. 2024 Apr;
30(8):1685-1695.
PMID: 38597991
Purpose: Combination therapies are a promising approach for improving cancer treatment, but it is challenging to predict their resulting adverse events in a real-world setting. Experimental Design: We provide here...
2.
Zegers A, Coenen P, Heeren A, Takke N, Ardon H, Compter A, et al.
J Cancer Surviv
. 2023 Oct;
19(1):326-338.
PMID: 37782399
Purpose: Many patients with a malignant (i.e., grade II-IV) glioma are of working age, yet they are rarely included in "cancer and work" studies. Here, we explored (1) the work-related...
3.
Burgers V, van den Bent M, Dirven L, Lalisang R, Tromp J, Compter A, et al.
Front Oncol
. 2022 Dec;
12:994934.
PMID: 36457502
Introduction: Increasingly more adolescent and young adult (AYA, aged 18-39 years) patients with an uncertain and/or poor cancer prognosis (UPCP) are gaining life-years because of novel treatments or refinement of...
4.
In t Veld S, Arkani M, Post E, Antunes-Ferreira M, DAmbrosi S, Vessies D, et al.
Cancer Cell
. 2022 Sep;
40(9):999-1009.e6.
PMID: 36055228
Cancer patients benefit from early tumor detection since treatment outcomes are more favorable for less advanced cancers. Platelets are involved in cancer progression and are considered a promising biosource for...
5.
Molenaar R, Coelen R, Khurshed M, Roos E, Caan M, van Linde M, et al.
BMJ Open
. 2017 Jun;
7(6):e014961.
PMID: 28601826
Introduction: High-grade chondrosarcoma, high-grade glioma and intrahepatic cholangiocarcinoma are aggressive types of cancer with a dismal outcome. This is due to the lack of effective treatment options, emphasising the need...
6.
Preusser M, Hoeftberger R, Woehrer A, Gelpi E, Kouwenhoven M, Kros J, et al.
Histopathology
. 2012 Feb;
60(6):885-94.
PMID: 22335622
Aims: To evaluate the prognostic value and clinical utility of Ki67 tumour cell proliferation index in anaplastic oligodendroglial tumours (AOT). Methods And Results: We performed anti-Ki67 immunostaining (MIB-1 antibody) of...
7.
Idbaih A, Dalmasso C, Kouwenhoven M, Jeuken J, Carpentier C, Gorlia T, et al.
J Neurooncol
. 2010 Sep;
103(2):221-30.
PMID: 20820870
Despite similar morphological aspects, anaplastic oligodendroglial tumors (AOTs) form a heterogeneous clinical subgroup of gliomas. The chromosome arms 1p/19q codeletion has been shown to be a relevant biomarker in AOTs...
8.
Idbaih A, Kouwenhoven M, Jeuken J, Carpentier C, Gorlia T, Kros J, et al.
Neuropathology
. 2008 Mar;
28(4):440-3.
PMID: 18312547
The chromosome (chr) 1p deletion is a favorable biomarker in oligodendroglial tumors and is even more powerful a marker when combined with chr 19q loss. As a result, the 1p...
9.
Kouwenhoven M, Ozenci V, Tjernlund A, Pashenkov M, Homman M, Press R, et al.
J Neuroimmunol
. 2002 May;
126(1-2):161-71.
PMID: 12020967
Dendritic cells (DC) are antigen-presenting cells (APC) that most efficiently initiate and control immune responses. Migration processes of blood DC are crucial to exert their professional antigen-presenting functions. Matrix-degrading metalloproteinases...
10.
Pashenkov M, Teleshova N, Kouwenhoven M, Smirnova T, Jin Y, Kostulas V, et al.
J Neuroimmunol
. 2002 Jan;
122(1-2):106-16.
PMID: 11777549
Dendritic cells (DC) accumulate in the CNS during inflammation and may contribute to local immune responses. Two DC subsets present in human cerebrospinal fluid (CSF) are probably recruited from myeloid...